Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Induction of IL-13 Triggers TGF-β1-Dependent Tissue Fibrosis in Chronic 2,4,6-Trinitrobenzene Sulfonic Acid Colitis

Stefan Fichtner-Feigl, Ivan J. Fuss, Cheryl A. Young, Tomohiro Watanabe, Edward K. Geissler, Hans-Jürgen Schlitt, Atsushi Kitani and Warren Strober
J Immunol May 1, 2007, 178 (9) 5859-5870; DOI: https://doi.org/10.4049/jimmunol.178.9.5859
Stefan Fichtner-Feigl
*Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
†Department of Surgery, University of Regensburg, Regensburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan J. Fuss
*Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl A. Young
*Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohiro Watanabe
*Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward K. Geissler
†Department of Surgery, University of Regensburg, Regensburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Jürgen Schlitt
†Department of Surgery, University of Regensburg, Regensburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Kitani
*Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Warren Strober
*Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Clinical features of chronic TNBS colitis in BALB/c mice. a, Body weight as a percentage of starting weight. Data shown are mean values ± SD derived from at least five mice per group. b, Masson’s trichrome staining of representative colon cross-sections during chronic TNBS colitis and chronic ethanol administration (magnification, ×5). c, Histological scores shown are mean values ± SD from at least five mice per group. d, Collagen content of the colon. Collagen content was determined during chronic TNBS colitis and chronic ethanol administration by a Sircol assay (see Materials and Methods). Data shown are mean values ± SD derived from at least five mice per group; ∗∗, p < 0.01.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Cytokine production of colonic LPMC at weekly time points during chronic TNBS colitis in BALB/c mice. LPMC were extracted from the lamina propria and cultured for 48 h in the presence of T cell or APC stimulants (see Materials and Methods). Cytokine concentrations in the culture supernatants were determined by cytokine-specific ELISA. Data shown are mean values ± SD from individual cultures of cells derived from mice in two separate experiments, each containing at least five mice per group; ∗, p < 0.05 and ∗∗, p < 0.01.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    In situ cytokine production in the colonic mucosa of mice with chronic TNBS colitis measured at weekly time points. Total colonic protein was extracted from mice in the various groups and subjected to cytokine-specific ELISAs. Data shown are representative of two independent experiments each containing at least five mice per group. Data shown are mean values ± SD derived from at least five mice per group; ∗, p < 0.05 and ∗∗, p < 0.01.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    IL-13 (a) and IL-4 (b) production by isolated colonic LPMC stimulated in vitro in the presence of anti-cytokine Abs. Cells were extracted from the lamina propria on day 42 of chronic TNBS colitis and cultured for 48 h in the presence of plate-bound anti-CD3 and soluble anti-CD28 as well as specific blocking Abs or control IgG. Cytokine concentrations in the supernatants were determined by ELISA. ∗, p < 0.05 and ∗∗, p < 0.01.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    IL-13Rα1 and IL-13Rα2 expression and function in BALB/c mice during the course of chronic TNBS colitis. a, IL-13Rα1 expression is constitutive whereas IL-13Rα2 expression is induced on day 35 during chronic TNBS colitis. IL-13Rα1 mRNA expression was determined by RT-PCR of RNA extracted from colonic LPMC, and IL-13Rα2 protein expression was determined by Western blot analysis analyzed of colonic LPMC lysates. b, IL-13 production after administration of pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1-Ab. Cells were extracted from the lamina propria and cultured for 48 h in the presence of plate-bound anti-CD3 and soluble anti-CD28. Cytokine concentration was determined in culture supernatants by ELISA. Data shown are mean values ± SD for the pooled data derived from two separate experiments. Groups in each experiment contained at least five mice; ∗∗, p < 0.01. c, IL-13Rα2 expression (but not IL-13Rα1) is reduced in chronic TNBS after treatment with pCI-sIL-13Rα2-Fc and IL-13Rα2-specific siRNA. IL-13Rα1 and IL-13Rα2 expression were determined as described in a. d, DNA-binding activity of c-jun in nuclear extracts of cells derived from isolated lamina propria is reduced after administration of pCI-sIL-13Rα2-Fc and IL-13Rα2-specific siRNA but not anti-TGF-β1-Ab. DNA-binding activity was determined in nuclear extracts from colonic lamina propria cells by the TransAM assay (see Materials and Methods). Data shown are mean values ± SD for the pooled data derived from three separate experiments. Groups in each experiment contained at least five mice; ∗∗, p < 0.01.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Body weight, collagen deposition, and histological scores of mice on day 49 of chronic TNBS colitis after administration of pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1 beginning on day 35 of chronic TNBS colitis. a, Body weight as a percentage of starting weight after administration of pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1-Ab (see text). Data shown are mean values ± SD derived from at least five mice per group. b, Masson’s trichrome staining of representative colon cross-sections during chronic TNBS colitis after administration of pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1-Ab (magnification, ×5). c, Histological scores after administration of pCI-sIL-13Rα2-Fc or anti-TGF-β1-Ab. Scores shown are mean values ± SD from at least five mice per group.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    LPMC cytokine production of mice on day 49 of chronic TNBS colitis after administration of pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1 beginning on day 35 of chronic TNBS colitis. Cells were extracted from the lamina propria and cultured for 48 h in the presence of plate-bound anti-CD3 and soluble anti-CD28. Cytokine concentration was determined in culture supernatants by ELISA. Data shown are mean values ± SD from individual cultures of cells derived from mice in two separate experiments, each containing at least five mice per group. Note that the scales used in these panels are frequently different from those used in Fig. 2, due to the lower cytokine production at this time point.

  • FIGURE 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 8.

    In situ cytokine production in the colonic mucosa of mice with chronic TNBS colitis measured after administration of pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1-Ab. Total colonic protein was extracted from mice in the various groups and subjected to cytokine-specific ELISAs. Data shown are mean values ± SD derived from at least five mice per group; ∗∗, p < 0.01.

  • FIGURE 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 9.

    TGF-β1 secretion by colonic lamina propria cells on day 49 of chronic TNBS colitis in BALB/c mice. a, TGF-β1 secretion after treatment with pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1-Ab. Cells were extracted from the lamina propria and cultured for 48 h in the presence of stimulants (see Materials and Methods). Cytokine concentration was determined in supernatants by ELISA. Data shown are mean values ± SD from two separate experiments. Groups in each experiment contained at least five mice; ∗∗, p < 0.01. b, Collagen content of the colon after administration of pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1-Ab. Collagen content was determined during chronic TNBS colitis by a Sircol assay. Data shown are mean values ± SD derived from at least five mice per group; ∗∗, p < 0.01.

  • FIGURE 10.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 10.

    Smad protein expression during the course of chronic TNBS colitis in BALB/c mice. a, pSmad3 is induced in the late phase (Day 35) of chronic TNBS colitis. pSmad3 in colonic LPMC lysates were analyzed by Western blot. b, Smad7 is expressed on day 7 and day 28 of chronic TNBS colitis. Smad7 level in colonic LPMC lysates was analyzed by Western blot. c, Expression of pSmad3 on day 49 of chronic TNBS colitis is inhibited after administration of pCI-sIL-13Rα2-Fc, IL-13Rα2-specific siRNA, or anti-TGF-β1-Ab. pSmad3 levels in colonic LPMC lysates were analyzed by Western blot. d, Smad7 is not expressed on day 49 of chronic TNBS colitis. Smad7 in colonic LPMC lysates was analyzed by Western blot.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 178 (9)
The Journal of Immunology
Vol. 178, Issue 9
1 May 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Induction of IL-13 Triggers TGF-β1-Dependent Tissue Fibrosis in Chronic 2,4,6-Trinitrobenzene Sulfonic Acid Colitis
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Induction of IL-13 Triggers TGF-β1-Dependent Tissue Fibrosis in Chronic 2,4,6-Trinitrobenzene Sulfonic Acid Colitis
Stefan Fichtner-Feigl, Ivan J. Fuss, Cheryl A. Young, Tomohiro Watanabe, Edward K. Geissler, Hans-Jürgen Schlitt, Atsushi Kitani, Warren Strober
The Journal of Immunology May 1, 2007, 178 (9) 5859-5870; DOI: 10.4049/jimmunol.178.9.5859

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Induction of IL-13 Triggers TGF-β1-Dependent Tissue Fibrosis in Chronic 2,4,6-Trinitrobenzene Sulfonic Acid Colitis
Stefan Fichtner-Feigl, Ivan J. Fuss, Cheryl A. Young, Tomohiro Watanabe, Edward K. Geissler, Hans-Jürgen Schlitt, Atsushi Kitani, Warren Strober
The Journal of Immunology May 1, 2007, 178 (9) 5859-5870; DOI: 10.4049/jimmunol.178.9.5859
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antigen presentation by dendritic cells in the aortic wall triggers T helper immune responses in atherosclerosis (54.16)
  • Eph receptors are involved in the pro-inflammatory response following spinal cord injury (54.21)
  • Liver sinusoidal endothelial cells undergo apoptosis during sepsis, leading to organ dysfunction. (54.13)
Show more Inflammation

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606